AWaRe classification of antibiotics for evaluation and monitoring of use, 2023

Overview

 

The AWaRe classification of antibiotics was developed in 2017 by the WHO Expert Committee on Selection and Use of Essential Medicines as a tool to support antibiotic stewardship efforts at local, national and global levels, Antibiotics are classified into three groups, Access, Watch and Reserve, taking into account the impact of different antibiotics and antibiotic classes on antimicrobial resistance, to emphasize the importance of their appropriate use. It is updated every 2 years.

The AWaRe classification is intended as a tool for monitoring antibiotic consumption, defining targets and monitoring the effects of stewardship policies that aim to optimize antibiotic use and curb antimicrobial resistance. The WHO 13th General Programme of Work 2019–2023 includes a country-level target of at least 60% of total antibiotic consumption being Access group antibiotics.


 

WHO Team
Essential Medicines (EML), Health Product Policy and Standards (HPS), Medicines Selection, IP and Affordability (MIA), WHO Headquarters (HQ)
Reference numbers
WHO Reference Number: WHO/MHP/HPS/EML/2023.04
Copyright